Pieris Pharmaceuticals Inc (PIRS)
17.00
-0.30
(-1.73%)
USD |
NASDAQ |
Nov 04, 16:00
17.00
0.00 (0.00%)
After-Hours: 20:00
Pieris Pharmaceuticals Total Assets (Quarterly): 25.05M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 25.05M |
| March 31, 2024 | 29.50M |
| December 31, 2023 | 38.68M |
| September 30, 2023 | 59.38M |
| June 30, 2023 | 87.54M |
| March 31, 2023 | 82.26M |
| December 31, 2022 | 95.49M |
| September 30, 2022 | 99.16M |
| June 30, 2022 | 114.31M |
| March 31, 2022 | 137.12M |
| December 31, 2021 | 153.56M |
| September 30, 2021 | 164.18M |
| June 30, 2021 | 155.03M |
| March 31, 2021 | 115.79M |
| December 31, 2020 | 105.01M |
| September 30, 2020 | 115.72M |
| June 30, 2020 | 117.78M |
| March 31, 2020 | 123.77M |
| December 31, 2019 | 141.10M |
| September 30, 2019 | 116.75M |
| June 30, 2019 | 130.84M |
| Date | Value |
|---|---|
| March 31, 2019 | 131.05M |
| December 31, 2018 | 141.34M |
| September 30, 2018 | 151.66M |
| June 30, 2018 | 162.02M |
| March 31, 2018 | 173.24M |
| December 31, 2017 | 103.88M |
| September 30, 2017 | 98.86M |
| June 30, 2017 | 105.96M |
| March 31, 2017 | 61.88M |
| December 31, 2016 | 35.06M |
| September 30, 2016 | 43.71M |
| June 30, 2016 | 46.45M |
| March 31, 2016 | 37.21M |
| December 31, 2015 | 33.95M |
| September 30, 2015 | 36.20M |
| June 30, 2015 | 14.48M |
| March 31, 2015 | 16.77M |
| September 30, 2014 | 0.0002M |
| June 30, 2014 | 0.0111M |
| March 31, 2014 | 0.0002M |
| December 31, 2013 | 0.0001M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
25.05M
Minimum
Jun 2024
164.18M
Maximum
Sep 2021
103.18M
Average
114.31M
Median
Jun 2022
Total Assets (Quarterly) Benchmarks
| Ligand Pharmaceuticals Inc | 866.40M |
| NovaBay Pharmaceuticals Inc | 3.925M |
| Palatin Technologies Inc | 10.74M |
| iBio Inc | 28.73M |
| Theriva Biologics Inc | 42.39M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 6.346M |
| Shareholders Equity (Quarterly) | 18.70M |